These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37031016)

  • 1. Neuroleptic malignant syndrome associated with atypical antipsychotics: A case report.
    Mogollon Díaz JP; Lizcano Toloza LY; Serrano García AY; Alquichire Luna CA; García Bohorquez DF; Chaparro Durán MF; Cáceres Valero MV
    Rev Colomb Psiquiatr (Engl Ed); 2023; 52(1):78-81. PubMed ID: 37031016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic Malignant Syndrome Associated with Atypical Antipsychotics: A Case Report.
    Mogollon Díaz JP; Lizcano Toloza LY; Serrano García AY; Alquichire Luna CA; García Bohorquez DF; Chaparro Durán MF; Cáceres Valero MV
    Rev Colomb Psiquiatr (Engl Ed); 2021 Jul; ():. PubMed ID: 34243899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
    Khouri C; Planès S; Logerot S; Villier C; Mallaret M
    Encephale; 2016 Jun; 42(3):277-80. PubMed ID: 26923996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic malignant syndrome due to olanzapine.
    Hall KL; Taylor WH; Ware MR
    Psychopharmacol Bull; 2001; 35(3):49-54. PubMed ID: 12397878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clozapine-associated neuroleptic malignant syndrome followed by catatonia: a case report].
    Erol A; Putgül G; Sert E; Mete L
    Turk Psikiyatri Derg; 2013; 24(2):140-4. PubMed ID: 23754268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suspected neuroleptic malignant syndrome in a patient receiving clozapine.
    Ganelin L; Lichtenberg PS; Marcus EL; Munter RG
    Ann Pharmacother; 1996 Mar; 30(3):248-50. PubMed ID: 8833560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reconsidering Rigidity in the Diagnosis of Neuroleptic Malignant Syndrome: A Case Report.
    El Khoury R; Kassab A; Dagher R; Javelot H; El Chammay R; Richa S
    J Psychiatr Pract; 2020 Jul; 26(4):320-323. PubMed ID: 32692129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic malignant syndrome associated with the use of prochlorperazine in a patient with a recent history of antipsychotic-induced neuroleptic malignant syndrome.
    Musselman ME; Browning LA; Parker D; Saely S
    Ann Pharmacother; 2011 Nov; 45(11):e61. PubMed ID: 21972252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic Malignant Syndrome with Normal Creatine Phosphokinase Levels: An Atypical Presentation.
    Zaidi S; Irfan N; Khalid Z
    J Coll Physicians Surg Pak; 2022 Apr; 32(4):S47-S48. PubMed ID: 35633010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and therapeutic challenges in neuroleptic malignant syndrome: a severe medical case.
    Brogna P; Colasuonno R; Di Michele F; Paterniti AM; Talamo A; Ribolsi M; Jannini TB; Siracusano A; Niolu C
    Riv Psichiatr; 2020; 55(4):236-239. PubMed ID: 32724236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical neuroleptic malignant syndrome - A case report.
    Vellekkatt F; Kuppili PP; Bharadwaj B; Menon V
    Asian J Psychiatr; 2019 Jun; 43():7-8. PubMed ID: 31071486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypicality in presentation of neuroleptic malignant syndrome caused by olanzapine.
    Mishra B; Mishra B; Sahoo S; Arora M; Khess CR
    Indian J Med Sci; 2007 Oct; 61(10):570-3. PubMed ID: 17932448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuroleptic malignant syndrome in a patient treated with olanzapine].
    Horni G; Meirik K; Lund MB
    Tidsskr Nor Laegeforen; 2003 Oct; 123(20):2867-9. PubMed ID: 14600711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The management challenges of a case with Flupentixol-induced neuroleptic malignant syndrome.
    Elyasi F; Sadati S; Heydari F
    Neuropsychopharmacol Rep; 2023 Mar; 43(1):154-159. PubMed ID: 36585735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuroleptic malignant syndrome: case report with recurrence associated with the use of olanzapine].
    Hanel RA; Sandmann MC; Kranich M; De Bittencourt PR
    Arq Neuropsiquiatr; 1998 Dec; 56(4):833-7. PubMed ID: 10029891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic malignant syndrome secondary to olanzapine, a presentation with severe acute kidney injury requiring hemodialysis: a case report.
    Chang CK; Payus AO; Noh MM; Lansing MG; Sumpat D; Lu SJA; Yew BT
    J Med Case Rep; 2022 Oct; 16(1):366. PubMed ID: 36203196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examining the Features of Neuroleptic Malignant Syndrome in Anti-NMDA Receptor Encephalitis: A Case-Control Study.
    Ramirez-Bermudez J; Restrepo-Martinez M; Espinola-Nadurille M; Martinez-Angeles V; Lopez-Hernandez JC; Hernandez-Vanegas LE; Martinez-Carrillo F; Ruiz-Garcia R; Rivas-Alonso V; Flores-Rivera J; Pollak TA
    J Acad Consult Liaison Psychiatry; 2024; 65(3):222-230. PubMed ID: 38151160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fever, confusion, acute kidney injury: is this atypical neuroleptic malignant syndrome following polypharmacy with clozapine and risperidone?
    Cherry S; Siskind D; Spivak V; Wysoczanski D; Halangoda P
    Australas Psychiatry; 2016 Dec; 24(6):602-603. PubMed ID: 27194777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
    Askenazy F; Dor E; Benoit M; Dupuis G; Serret S; Myquel M; Seddiki Y
    Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.